Marker Therapeutics, Inc. (MRKR)
2.00
-0.07
(-3.38%)
USD |
NASDAQ |
Jan 09, 16:00
2.05
+0.05
(+2.50%)
After-Hours: 20:00
Marker Therapeutics Total Assets (Quarterly): 21.73M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 568.69M |
| Viridian Therapeutics, Inc. | 577.14M |
| Neurocrine Biosciences, Inc. | 4.266B |
| Kiniksa Pharmaceuticals International Plc | 712.33M |
| AIM ImmunoTech, Inc. | 5.494M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.346M |
| Shareholders Equity (Quarterly) | 18.39M |
| Current Ratio | 6.496 |